Noteworthy
First DHMC Radiation Oncology Residency Program graduate, Gobind Gill, MD, joins U of Alabama.
Kelli Pointer, MD, PhD, receives ASTRO-ACS Clinician Scientist Development Grant for her work in overcoming radiation resistance in gliomas.
Starting September 30, all Dartmouth Cancer Center Manchester appointments will take place at Dartmouth Hitchcock Clinics, 100 Hitchcock Way, Manchester.
Supporting Breast Cancer Survivors: Join the Comprehensive Breast Program on October 17 for an event of learning and inspiration. RSVP today.
Garret Wasp, MD, receives National Cancer Institute grant to improve the approach to decisions around when to stop treatment for advanced cancer.
DCC Radiation Oncology will deliver 11 oral and poster presentations at annual American Association of Physicists in Medicine conference.
A Fresh Approach to Lung Cancer Screening
How a team at Dartmouth is working to improve lung cancer screening rates to save more lives.
Noteworthy
First DHMC Radiation Oncology Residency Program graduate, Gobind Gill, MD, joins U of Alabama.
Kelli Pointer, MD, PhD, receives ASTRO-ACS Clinician Scientist Development Grant for her work in overcoming radiation resistance in gliomas.
Starting September 30, all Dartmouth Cancer Center Manchester appointments will take place at Dartmouth Hitchcock Clinics, 100 Hitchcock Way, Manchester.
Supporting Breast Cancer Survivors: Join the Comprehensive Breast Program on October 17 for an event of learning and inspiration. RSVP today.
Garret Wasp, MD, receives National Cancer Institute grant to improve the approach to decisions around when to stop treatment for advanced cancer.
DCC Radiation Oncology will deliver 11 oral and poster presentations at annual American Association of Physicists in Medicine conference.
Experience the Dartmouth Cancer Center difference
Award-winning patient experience
Our patients rank us in the top 5% of healthcare organizations nationwide, earning us the Press Ganey Human Experience Pinnacle of Excellence Award 4 years in a row.
Highest NCI designation
Patient outcomes can improve by up to 25% when treated at an NCI-designated comprehensive cancer center.
Coordinated care
At Dartmouth Cancer Center, we don't treat a disease, we treat a person—a whole person. Our care team makes it easy to coordinate care, beyond just cancer treatment.
Clinical trials impact the future of healthcare
Clinical trials give cancer researchers information they need to discover new ways to prevent, find, and treat cancer. Many options available today would not be possible without clinical trials. Today's trials will build upon what we know to help future generations. Research like this depends upon all kinds of people taking part.
To find clinical trials at Dartmouth Cancer Center that are open and enrolling people, please visit Find a Clinical Trial or talk with your provider to discuss your options.
As one of 57 National Cancer Institute-designated Comprehensive Cancer Centers in the United States, and one of three in New England, our clinicians and scientists are working daily to bring their innovations directly to patients while delivering cutting-edge cancer treatments.